Free Stipulation - District Court of Delaware - Delaware


File Size: 77.0 kB
Pages: 2
Date: December 31, 1969
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 424 Words, 2,604 Characters
Page Size: 614 x 790 pts
URL

https://www.findforms.com/pdf_files/ded/8292/86.pdf

Download Stipulation - District Court of Delaware ( 77.0 kB)


Preview Stipulation - District Court of Delaware
Case 1 :04-cv-00940-JJF Document 86 Filed 1 1/06/2006 Page 1 of 2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
THE PROCTER & GAMBLE COMPANY, )
)
Plaintiff, )
V· ) C.A. No. 04-940 (UF)
)
TEVA PHARMACEUTICALS USA, INC. )
)
Defendant, )
l
STIPULATION AND ORDER
IT IS HEREBY STIPULATED AND AGREED by and between plaintiff, The Procter &
Gamble Co. ("P&G”) and defendant, Teva Pharmaceuticals USA, Inc.:
1. Pursuant to a stipulation submitted by the parties on January 27, 2006 and
approved by the Court on February 2, 2006, Teva previously stipulated that the commercial
marketing of Teva’s proposed 5 mg, 30 mg, and 35 mg risedronate sodium tablets, in accordance
with ANDA No. 77-132, would infringe claims 4, ll, 12, l4, 16 and 23 of U.S. Patent No.
5,583,122 (the "’ 122 patent") if those claims are valid. Given the stipulations below, Teva’s
stipulation of infringement of claims ll, l2, and 14 is hereby withdrawn.
2. For purposes ofthe above captioned litigation only, P&G agrees that it intends to
pursue judgment with respect to claims 4, 16, and 23 of the ‘122 patent only.
3. P&G has infonned Teva that, for purposes of the above captioned litigation only,
it will not pursue at trial the argument that claims 4, 16, and 23 of the ’l22 patent are described
in the ’543 application.
na02;ss<¤zs6z.r ossasarozi

Case 1:04-cv-00940-JJF Document 86 Filed 11/06/2006 Page 2 of 2
4. This stipulation is not evidence ofthe invalidity of any claim in the ‘l22 patent or
any other patent belonging to P&G.
RICHARDS LAYTON & FINGER, P.A. YOUNG CONAWAY STARGATT &
TAYLOR, LLP
/5/ €Fret{eric@L. Cottreff /5/ Karen L. Q’a5ca&
Frederick L. Cottrell (No. 2555) Josy W. Ingersoll (No. 1088)
Steven J. Fineman (No. 4025) Karen L. Pascale (No. 2903)
One Rodney Square The Brandywine Building
_ P.O. Box 551 1000 West Street, 17m Floor
Wilmington, DE l9899-039l Wilmington, DE 19899-055l
Telephone: (302) 65l—7700 Telephone: (302) 571-6600
flI1€ITlE111@l`lT`.COl1f1 [email protected]
QfC0w1sel: Of Counsel:
William F. Lee James Galbraith
David B. Bassett Maria Luisa Palmese
Cynthia D. Vreeland Antony Pfeffer
Vinita Ferrera KENYON & KENYON LLP
WILMER CUTLER PICKERING One Broadway
I-IALE AND DORR LLP New York, NY 10004
60 State Street Telephone: (212) 425-7200
Boston, MA 02109
Telephone: (617) 526-6000
Attorrzeysfor The Procter & Gamble Attorneys for Teva P/tarmaceuticals
Company USA, Inc.
SO ORDERED this day of November, 2006.
UNITED STATES DISTRICT JUDGE
oB02;5592s usrnocs sisgmu ~